Piragrel is a potent direct thrombin inhibitor used as an oral anticoagulant for the prevention and treatment of venous thromboembolism in patients managing conditions such as atrial fibrillation or mechanical… Read more
Piragrel is a potent direct thrombin inhibitor used as an oral anticoagulant for the prevention and treatment of venous thromboembolism in patients managing conditions such as atrial fibrillation or mechanical heart valves. This category includes high-quality reference standards essential for pharmaceutical analysis, supporting both the parent drug and its related substances. Analytical chemists rely on these Piragrel impurity standards to facilitate precise impurity profiling and the validation of quantification methods during drug development and stability testing. Furthermore, the inclusion of stable isotope labelled compounds, such as the deuterated analogue, allows for accurate identification and quantification through isotopic dilution analysis in complex matrices. These materials provide the necessary tools for rigorous quality control assays, ensuring regulatory compliance and the maintenance of product integrity throughout the pharmaceutical lifecycle.